Got $300? 2 Biotech Stocks to Buy and Hold Forever
The Motley Fool
by newsfeedback@fool.com (James Halley)February 16, 2026
These two biotechs only have one marketable therapy each, but both have blockbuster potential.
Verticals
financeinvesting
Originally published on The Motley Fool on 2/16/2026